- CONSORT Statement
- CONSORT Statement Extensions
- Evidence underpinning CONSORT
- Accrual and sample size
- Attitudes to trials
- Adverse events (Harms)
- Baseline data
- Blinding
- Compliance
- Early stopping
- Eligibility
- Follow-up
- Funding
- Harms
- Generalizability
- Intention to treat
- Interpretation
- Interventions
- Outcome reporting
- Random allocation
- Recruitment
- Statistical analysis
- Statistical methods
- Trial design issues
- Trial registration
- Uptake of CONSORT by journals
- Impact of and adherence to CONSORT
- Endorsement of CONSORT
Follow-up
Altman DG, de Stavola BL, Love SB,
Stepniewska KA. Review of survival analyses published in cancer journals. Br J
Cancer 1995; 72(2):511-518.
PMID: 7640241
Juni P, Egger M. Commentary: Empirical evidence of
attrition bias in clinical trials. Int J Epidemiol 2005; 34(1):87-88.
PMID: 15649954
Karlson CW, Rapoff MA. Attrition in Randomized Controlled Trials for Pediatric Chronic Conditions. J Pediatr Psychol 2008;
PMID: 19064607 [New]
Sackett DL, Gent M. Controversy in counting and attributing
events in clinical trials. N Engl J Med 1979; 301(26):1410-1412.
PMID: 514321
Shuster JJ. Median follow-up in clinical trials. J Clin
Oncol 1991; 9(1):191-192.
PMID: 1985169
Page last edited: 05 May 2009
